Back to User profile » Dr Matteo Fontana
Papers published by Dr Matteo Fontana:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life
Menzella F, Fontana M, Contoli M, Ruggiero P, Galeone C, Capobelli S, Simonazzi A, Catellani C, Scelfo C, Castagnetti C, Livrieri F, Facciolongo N
Journal of Asthma and Allergy 2022, 15:505-515
Published Date: 21 April 2022
A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)
Menzella F, Fontana M, Galeone C, D'Amato M, Canonica GW, Ghidoni G, Capobelli S, Scelfo C, Simonazzi A, Catellani C, Ruggiero P, Facciolongo N
Journal of Asthma and Allergy 2021, 14:1019-1031
Published Date: 13 August 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
May 2020: Is It Always COVID-19 No Matter What?
Livrieri F, Ghidoni G, Piro R, Menzella F, Cavazza A, Lazzaretti C, Massari M, Montanari G, Fontana M, Facciolongo NC
International Medical Case Reports Journal 2020, 13:563-567
Published Date: 2 November 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports
Scelfo C, Fontana M, Casalini E, Menzella F, Piro R, Zerbini A, Spaggiari L, Ghidorsi L, Ghidoni G, Facciolongo NC
Therapeutics and Clinical Risk Management 2020, 16:1039-1046
Published Date: 29 October 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
Menzella F, Ruggiero P, Ghidoni G, Fontana M, Bagnasco D, Livrieri F, Scelfo C, Facciolongo N
Journal of Asthma and Allergy 2020, 13:301-313
Published Date: 9 September 2020